(CRVS) Corvus Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Corvus Pharmaceuticals | (CRVS) share price targets
Complete technical analysis of Corvus Pharmaceuticals (CRVS) by charts plus indicators, forecast predictions and share price targets for Corvus Pharmaceuticals (CRVS)
Corvus Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-05 View latest technical analysis
10 day averaged volume of Corvus Pharmaceuticals is 373990
Date | Daily Closing Price | Open | High | Low | Volume |
05 Thu Sep 2024 | 4.00 | 4.08 | 4.15 | 3.92 | 0.852 times |
04 Wed Sep 2024 | 4.06 | 4.00 | 4.22 | 3.97 | 0.571 times |
03 Tue Sep 2024 | 4.04 | 4.45 | 4.60 | 3.90 | 1.317 times |
30 Fri Aug 2024 | 4.48 | 4.20 | 4.75 | 4.16 | 2.125 times |
30 Fri Aug 2024 | 4.48 | 4.20 | 4.75 | 4.16 | 2.125 times |
29 Thu Aug 2024 | 4.14 | 4.12 | 4.20 | 3.99 | 0.521 times |
28 Wed Aug 2024 | 4.10 | 4.04 | 4.18 | 3.91 | 0.784 times |
27 Tue Aug 2024 | 4.07 | 4.06 | 4.15 | 3.97 | 0.503 times |
26 Mon Aug 2024 | 4.13 | 4.30 | 4.35 | 3.87 | 0.899 times |
23 Fri Aug 2024 | 4.30 | 4.20 | 4.30 | 4.05 | 0.618 times |
My analysis of stock is bearish for shortterm, and stock might move down till 3.8 or till 3.5. Use a stoploss of 4.07 and if the stock hits stoploss, then it can shoot up till 4.31
Share price targets for Corvus Pharmaceuticals (CRVS)
Target Type | Value |
Downside Target | 1.43 |
Downside Target | 1.75 |
Downside Target | 2.28 |
Downside Target | 2.35 |
Downside Target | 2.47 |
Downside Target | 3.00 |
Downside Target | 3.46 |
Downside Target | 3.87 |
Upside Target | 4.10 |
Upside Target | 4.30 |
Upside Target | 4.60 |
Upside Target | 4.75 |
Intraday share price targets for Corvus Pharmaceuticals (CRVS)
Target Type | Value |
Downside Intraday Target | 3.73 |
Downside Intraday Target | 3.47 |
Upside Intraday Target | 4.43 |
Upside Intraday Target | 4.87 |
Upside Intraday Target | 4.17 |
Weekly technical analysis of Corvus Pharmaceuticals (CRVS)
Date | Weekly Closing Price | Open | High | Low | Volume |
05 Thu Sep 2024 | 4.00 | 4.45 | 4.60 | 3.90 | 1.29 times |
30 Fri Aug 2024 | 4.48 | 4.20 | 4.75 | 4.16 | 0.44 times |
30 Fri Aug 2024 | 4.48 | 4.30 | 4.75 | 3.87 | 1 times |
23 Fri Aug 2024 | 4.30 | 3.97 | 4.30 | 3.96 | 0.819 times |
16 Fri Aug 2024 | 4.10 | 4.00 | 4.10 | 3.46 | 0.712 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Corvus Pharmaceuticals (CRVS)
Date | Monthly Closing Price | Open | High | Low | Volume |
05 Thu Sep 2024 | 4.00 | 4.45 | 4.60 | 3.90 | 0.094 times |
30 Fri Aug 2024 | 4.48 | 2.74 | 4.75 | 2.47 | 3.106 times |
31 Wed Jul 2024 | 2.57 | 1.81 | 3.00 | 1.75 | 1.015 times |
28 Fri Jun 2024 | 1.82 | 2.15 | 2.28 | 1.78 | 0.456 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Corvus Pharmaceuticals (CRVS)
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Corvus Pharmaceuticals in short term but the sell signal is initial and weak.
Corvus Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Corvus Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Corvus Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.25 and Corvus Pharmaceuticals (CRVS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Corvus Pharmaceuticals in short term but the sell signal is initial and weak.
Corvus Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Corvus Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Corvus Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.25 and Corvus Pharmaceuticals (CRVS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.